Google
MAIA — MAIA BIOTECHNOLOGY INC. (Healthcare >> Biotechnology)
MAIA FAQ
What is MAIA's ROE?
MAIA BIOTECHNOLOGY INC. reports a Return on Equity (ROE) of -87.34%.
What is MAIA's dividend yield?
MAIA BIOTECHNOLOGY INC. offers a dividend yield of 0.00%.
What is MAIA's Deepscope Quality Score?
Deepscope rates MAIA's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy MAIA?
Deepscope's AI Timing Score for MAIA is 50 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does MAIA belong to?
MAIA BIOTECHNOLOGY INC. is classified under the Healthcare >> Biotechnology sector on the NYSE MKT exchange.
|
USD 1.36
Price
-0.09
(-6.62%)
Day Change
|
|
|---|
MAIA, the overall quality is not good ( Quality = 38) and the timing to buy is ...(Sign In to See)...
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROA is too relatively low compare to ROE
Acceleration of ROA growth rate is below our criteria.
Net profit margin is relatively low.
Acceleration of net profit margin growth rate is below our criteria
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is not good , ...
| Quality Factors |
|
42% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 61 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 1.36 |
| PBV / Sector |
3.13 / 4.63
|
| Earning Per Share | -0.38 |
| PE / Sector |
N/A / 17.43
|
| PEG or PE/Growth / Sector |
N/A / 0.53
|
| Average 1M Daily Value |
1.32 M
GREAT
|
| Average 1W Daily Value |
3.11 M
GREAT
|
| Timing Factors |
|
71% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
37% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-06 09:08:51 |
| Symbol | MAIA |
| Name | MAIA BIOTECHNOLOGY INC. |
| Sector | Healthcare >> Biotechnology |
| Market | NYSE MKT |
| Listed Shares | 60.80 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 86.95 / 8,857.28 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 444 West Lake Street, Chicago, IL, United States, 60606
Phone: 312 416 8592
Website: https://maiabiotech.com
Sector: Healthcare >> Biotechnology
Description: MAIA Biotechnology, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the development of targeted immunotherapies for cancer. Its lead product Ateganosine, a telomere-targeting agent currently in clinical development to evaluate its activity in Non-Small Cell Lung Cancer (NSCLC). The company was incorporated in 2018 and is headquartered in Chicago, Illinois.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
